Magisto is represented by Barak Platt, Daniel Damboritz, Ezra Gross, Eli Greenbaum, Dr. Eran Lempert, Josh Hauser, Miriam Friedmann and Shay Fahima.
Adv. Daniel Green represented Reshef Technologies, an Israeli company, in negotiations with Baharat Electronics, one of India's largest defense companies, for a strategic technology transfer and supply agreement worth tens of millions of dollars. The transaction also included assistance in establishing a plant in India for assembling electronic fuses for land-based ammunition.
Advs. Daniel Green and Eli Greenbaum represented Oramed Pharmaceuticals, an Israeli clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, in a licensing transaction with Hefei Tianhui Incubator of Technologies Co., Ltd., of China. The agreement is worth $38 million, with future royalties, and gives HTIT exclusive rights to market Oramed’s oral insulin capsule, in China, Hong Kong and Macau. This deal is alongside a $12 million equity investment in the company.
Advocates Barak S. Platt, Ben Sandler, Ofir Levy, Daniel Green, Eli Greenbaum and Nimrod Vromen represented Clarity Ray, an Israeli startup company developing tools helping publishers and networks identify and prevent ad-fraud, in its acquisition by Yahoo!.
Adv. Kobi Ben Chitrit and Liron Hacohen represented the Company's lead investor, Mr. Saar Wilf.
Clarity Ray's employees will be used by Yahoo! to form its new local R&D hub focusing on internet search frauds.
Adv. Simon Weintraub lectured at the 6th Plenary Meeting of the European Technology Transfer Offices (TTO) Circle co-organised by the Weizmann Institute of Science and the European Commission’s Joint Research Centre (JRC).
Advocates Barry Levenfeld, Harry Kirsh, Yuval Shalhevet, Zohar Nevo and Noam Enk represents the winning bidding consortium, consisting of Johnson & Johnson, Takeda Pharmaceuticals (the first Japanese Pharmaceutical Company to invest in Israel) and the healthcare fund OrbiMed Israel, for the establishment of an OCS-supported biotechnological incubator intended to encourage the creation and support of pharmaceutical and medical device companies.
Yigal Arnon & Co., in cooperation with IATI, is hosting a Professional Session for start-ups and entrepreneurs on Thursday, July 4, 2013 at 19:00, at TECHLOFT, Tel Aviv
Advs. Barry Levenfeld, Eric Spindel, Avigail Frisch and Noam Enk represented Aegis for Alcobra Ltd.'s initial public offering on Nasdaq. Alcobra Ltd., headquartered in Israel, is an emerging biopharmaceutical company primarily focused on the development and commercialization of a proprietary drug to treat Attention Deficit Hyperactivity Disorder.